Please assess the completion status of the following clinical trial:

Trial Title: Electromyographic Assessment of Onset and Recovery of Neuromuscular Blockade

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* American Society of Anesthesiologists Status I to III patients requiring neuromuscular blockade in the operating room will be eligible for enrollment~Exclusion Criteria:~* 1) presence of an underlying neuromuscular disease; 2) use of drugs known to interfere with neuromuscular transmission (antiseizure medications, anticholinesterases, magnesium sulfate); 3) presence of renal or hepatic disease; or 4) procedures preventing access to at least one of the upper extremities.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Acceleromyography group (Type: None): Train-of-four ratio calculation (TOF-Watch-SX-Bluestar enterprise)
- Electromyography group (Type: None): Train-of-four ratio calculation (T4-EMG)

Based on this trial design, predict the completion outcome and termination type (if applicable).